Neuberger Berman Group LLC Novavax Inc Transaction History

Neuberger Berman Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $391,642 - $812,755	10,795 Added 390.56%	13,559 $697,000
Q1 2022 May 23, 2022	BUY	$69.73 - $142.9 $192,733 - $394,975	2,764 New	2,764 $204,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $142,876 - $292,802	-2,049 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $275,713 - $446,620	2,049 New	2,049 $238,000
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $675,785 - $1.44 Million	-5,585 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $333,516 - $944,433	-2,952 Reduced 34.58%	5,585 $971,000
Q4 2020 Feb 10, 2021	BUY	$78.74 - $139.5 $2,913 - $5,161	37 Added 0.44%	8,537 $948,000
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $675,240 - $1.52 Million	8,500 New	8,500 $920,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.